Literature DB >> 1446849

Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship.

E Brenna1, H L Waldum.   

Abstract

Gastrin was given to rats by continuous subcutaneous infusion through implanted osmotic minipumps in doses covering a wide range of the dose response relationship for gastrin with regard to the trophic effect on the enterochromaffin like cells of the oxyntic mucosa. Thirty five rats were divided into five groups (each of seven rats), one group receiving a control solution of 1% albumin, the others receiving gastrin in 1% albumin at doses of 2.5, 5, 10, and 15 micrograms/kg/h, respectively. The plasma gastrin concentrations in the various groups increased in the same order of magnitude as expected from the gastrin doses given. Gastrin induced a dose dependent increase in enterochromaffin like cell density, oxyntic mucosal histamine concentration and histidine decarboxylase activity up to the dose of 5 micrograms/kg/h, where the increase levelled off. Hence, the dose response relationship for the trophic effect of gastrin on the enterochromaffin like cells seems to follow a polynomial rather than a linear function. These findings may also contribute to the understanding of the trophic effect of gastrin on enterochromaffin like cells in man with conditions associated with hypergastrinaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446849      PMCID: PMC1379593          DOI: 10.1136/gut.33.10.1303

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  The pentagastrin-induced gastric acid response in humans.

Authors:  R Leth; L Olbe; U Haglund
Journal:  Scand J Gastroenterol       Date:  1988-03       Impact factor: 2.423

2.  Histamine metabolism in human gastric mucosa. Effect of pentagastrin stimulation.

Authors:  H Lönroth; E Rosengren; L Olbe; L Lundell
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

3.  Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

Authors:  S M Sjöblom; P Sipponen; S L Karonen; H J Järvinen
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

4.  Electron microscopic radioautographic identification of the ECL cell as the histamine-synthesizing endocrine cell in the rat stomach.

Authors:  W Rubin; B Schwartz
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

5.  Localization of cells containing and forming histamine in the gastric mucosa of the rat.

Authors:  R Thunberg
Journal:  Exp Cell Res       Date:  1967-08       Impact factor: 3.905

6.  Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity.

Authors:  R Håkanson; J H Kroesen; G Liedberg; J Oscarson; J F Rehfeld; F Stadil
Journal:  J Physiol       Date:  1974-12       Impact factor: 5.182

7.  Variable contribution of gastrin to gastric acid secretion after a meal in humans.

Authors:  A J Blair; C T Richardson; J H Walsh; M Feldman
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

8.  Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.

Authors:  H Mattsson; N Havu; J Bräutigam; K Carlsson; L Lundell; E Carlsson
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

9.  Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach.

Authors:  B Ryberg; A E Bishop; S R Bloom; E Carlsson; R Håkanson; H Larsson; H Mattsson; J M Polak; F Sundler
Journal:  Regul Pept       Date:  1989-05

10.  Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies.

Authors:  R Håkanson; G Böttcher; E Ekblad; P Panula; M Simonsson; M Dohlsten; T Hallberg; F Sundler
Journal:  Histochemistry       Date:  1986
View more
  17 in total

Review 1.  Antiulcer drugs and gastric cancer.

Authors:  Helge L Waldum; Bjørn Gustafsson; Reidar Fossmark; Gunnar Qvigstad
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  Marked increase in gastric acid secretory capacity after omeprazole treatment.

Authors:  H L Waldum; J S Arnestad; E Brenna; I Eide; U Syversen; A K Sandvik
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 3.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

4.  Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.

Authors:  G E Feurle
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut.

Authors:  O Brenna; G Qvigstad; E Brenna; H L Waldum
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

6.  Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats.

Authors:  I D Penman; E el-Omar; J R McGregor; K J Hillan; P J O'Dwyer; K E McColl
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

7.  Hypergastrinemia and enterochromaffin-like cell hyperplasia.

Authors:  G Delle Fave; M Marignani; A Moretti; G D'Ambra; G Martino; B Annibale
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 8.  Relationship of ECL cells and gastric neoplasia.

Authors:  H L Waldum; E Brenna; A K Sandvik
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 9.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Classification of tumours.

Authors:  Helge L Waldum; Arne K Sandvik; Eiliv Brenna; Reidar Fossmark; Gunnar Qvigstad; Jun Soga
Journal:  J Exp Clin Cancer Res       Date:  2008-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.